Abstract
The 176-item Sleep Disorders Questionnaire (SDQ) was initially developed using canonical discriminant function analysis on 4 groups of sleep disorder patients, but it was never studied by factor analysis in its entirety. Several authors have criticized 2 of its subscales as being confounded with each other, and its narcolepsy scale as substantially over-diagnosing narcolepsy. This study describes its first exploratory factor analysis (EFA), the intent of which was to reassess item membership on the 4 existing subscales and to derive new scales to improve differential diagnosis between patient groups. It was also hoped that EFA could reduce the total number of questions, to increase speed of completion. The EFA was performed on the anonymized SDQ results from a retrospective review of the charts of 2131 persons from 7 sleep disorders clinics and research centers. Factors were assessed via scree plots and eigenvalues. The EFA identified four main factors: insomnia, daytime sleepiness, substance use, and sleep-disordered breathing. The insomnia factor had 3 subfactors: psychological symptoms of insomnia, subjective description of insomnia, and insomnia due to periodic limb movements. The sleepiness factor had two subfactors: daytime sleepiness and neurological symptoms of narcolepsy. The novel substance use factor was homogeneous, as was the sleep-disordered breathing factor. Importantly, the EFA reassigned items from the original SDQ’s NAR, PSY, and PLM subscales to five of the new subscales. The Sleep Apnea (SA) subscale emerged mostly unchanged. The 7 resulting factors comprised only 66 items of the original 176-item SDQ. These results have allowed the creation of a new shorter questionnaire, to be called the SDQ-2. External validation of the SDQ-2 is currently underway. It will likely prove to be a superior differential diagnostic instrument for sleep disorders clinics, compared to the original SDQ.
Competing Interest Statement
I have read the journal's policy and the authors of this manuscript have the following competing interests: Dr. Douglass retains a copyright on the resulting SDQ-2 questionnaire and could benefit from its commercialization
Funding Statement
KB received a Canada Graduate Scholarship (CGS) from the (Canadian) Natural Sciences and Engineering Research Council (NSERC) that supported her PhD studies on this project. https://www.nserc-crsng.gc.ca/ The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
University of Ottawa Social Sciences and Humanities Research Ethics Board (File 02-08-16), secondary use of anonymized data was approved. The project was also approved (File number 2008001) by the Research Ethics Board of the Royal Ottawa Hospital, Ottawa, ON, Canada.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Data Availability
All relevant data are within the manuscript and its Supporting Information files (if the editor agrees to publish the file size of 2131 rows by 169 columns).
List of Abbreviations
- Berlin Questionnaire
- screening questionnaire for sleep apnea
- BMI
- Body Mass Index (kg/m2)
- EFA
- exploratory factor analysis
- ESS
- Epworth Sleepiness Scale
- GAD-7
- Generalized Anxiety Disorder, 7-item scale
- MIES
- Moral Injury Events Scale
- NAR, PSY, PLM, SA
- subscales of the original SDQ
- OSA
- obstructive sleep apnea
- PCL-5
- PTSD Checklist for DSM-5
- PHQ-9
- Patient Health Questionnaire (depression)
- PLM
- periodic limb movements
- PSQI
- Pittsburgh Sleep Quality Index
- RLS
- Restless Legs Syndrome
- ROC
- receiver operating characteristics (analysis)
- SDB
- sleep disordered breathing
- SDQ
- the original Sleep Disorders Questionnaire, 1994
- SDQ-2
- second edition of the SDQ, derived in the present paper
- SQAW
- Stanford University’s Sleep Questionnaire and Assessment of Wakefulness
- STOP-Bang
- screening questionnaire for sleep apnea
- TIA
- transient ischemic attack
- CAGE
- alcohol screening questionnaire
- ISI
- Insomnia Severity Index
